Concept Foundation has contributed to the 2018 Maternal Health Campaign. Learn more about the impact of poor quality medicines from key thought leaders.
Quality Matters: Cheap Uterotonics – Bargain or Burden?
person
folder_openMaternal Health, Quality
Fiona Theunissen, MBA and Dr Hans Vemer, CEO of Concept Foundation and former obstetrician, discuss why quality, which is by no means a given, is such an important consideration when purchasing maternal health medicines such as uterotonics.
News & Events
- We Need More Pharmaceutical R&D to Improve Maternal Health
- WHO Prequalifies a 2nd generic DMPA product with Concept Foundation support
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
- A third quality assured, generic DMPA-IM product available for procurement